How to Help Your Patients Find Plaquenil in Stock: A Provider's Guide

Patients taking Plaquenil (hydroxychloroquine) for lupus or rheumatoid arthritis often contact their prescribing provider when they can't find it at their pharmacy. While the primary work of tracking down medications falls on the patient, providers who are armed with practical strategies and pharmacy resources can significantly reduce the burden on their patients and their own staff. This guide is designed for rheumatologists, PCPs, dermatologists, and their care team members.

Why Patients Can't Always Find Hydroxychloroquine on Their Own

Many of your patients managing lupus or RA are dealing with fatigue, brain fog, pain, or other symptoms that make extended phone searches difficult. The process of calling five or more pharmacies, being placed on hold, and navigating automated systems can take hours for a healthy person—it can be genuinely prohibitive for someone in a flare. As a result, some patients simply give up and go without their medication, which creates clinical risk.

Step 1: Create a Preferred Pharmacy List for Your Practice

Designate 2–3 pharmacies near your practice that consistently carry hydroxychloroquine from reliable manufacturers. These may include independent pharmacies, specialty pharmacies, or hospital outpatient pharmacies. Keep this list on file so staff can refer patients immediately. Update it quarterly—supply sources change.

Step 2: Direct Patients to medfinder

medfinder is a service that calls pharmacies on behalf of patients to identify which ones have a specific medication in stock. Patients provide their medication (Plaquenil or hydroxychloroquine), dosage, and ZIP code. medfinder calls local pharmacies and texts the patient a list of which ones have it. This eliminates hours of hold time for patients who are already struggling. Direct patients to medfinder.com or add it to your patient education handouts for medication access issues.

Step 3: Prescribing Strategies That Reduce Supply Problems

Simple prescribing adjustments can dramatically reduce how often your patients run into supply problems:

• Prescribe 90-day supplies. Hydroxychloroquine is not a controlled substance. Most plans will cover 90-day fills for maintenance medications. This reduces the refill burden from monthly to quarterly.
• Write for brand when necessary. If generic stock is consistently unavailable and brand Plaquenil is accessible through your patient's plan, a Dispense As Written (DAW) prescription for brand-name Plaquenil (Concordia, 200 mg) can solve the supply problem even when generics are unavailable.
• Route to mail-order for stable patients. Stable patients on long-term therapy are ideal candidates for mail-order pharmacy, which typically has better supply chain relationships than retail pharmacies and fills 90-day supplies.
• Consider Costco or Walmart pharmacies. These pharmacies maintain strong supply of high-volume generic medications. They are worth recommending when chain pharmacies near the patient are out of stock.

Step 4: Identify Which Patients Need Most Immediate Help

Not all patients are equally at risk from a supply interruption. Given hydroxychloroquine's long half-life (approximately 40–50 days), a 1-week gap is unlikely to cause clinical harm in a stable patient. Triage your outreach accordingly:

• Urgent (call within 24 hours): SLE patients with recent flares, active nephritis, or cardiopulmonary involvement
• High priority (call within 48 hours): SLE patients in remission on HCQ; RA patients with moderate-to-severe disease on combination therapy
• Routine follow-up: RA patients in remission on HCQ monotherapy with no recent activity

Sample Patient Communication Language

Here's suggested language for staff when a patient calls about a supply problem with their hydroxychloroquine:

Script: "We understand this is frustrating. Your medication is available at multiple pharmacies—it may just take a few calls to find one that has it. We'd recommend using a service called medfinder (medfinder.com), which calls pharmacies on your behalf and texts you which ones have it in stock. If you're unable to find it within 48 hours, please call us back and we'll help coordinate directly with a pharmacy."

When to Escalate to a Clinical Discussion

If a patient has been without hydroxychloroquine for more than 2 weeks, schedule a clinical check-in. Assess for early flare signs in SLE patients (fatigue, rash, joint swelling, photosensitivity) and RA patients (increased joint pain or stiffness). If a prolonged gap is anticipated (more than 4 weeks), discuss a formal bridge plan—whether that involves a temporary corticosteroid course, an alternative DMARD, or a biologic escalation.

For more clinical context, see also: Plaquenil Shortage: What Providers and Prescribers Need to Know in 2026.